Ropinirole

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 939 publications

Restless Legs Syndrome: A Review.

Restless Legs Syndrome: A Review.

Journal: JAMA

Published: January 21, 2026

Exploring the Pharmaceutical Significance and Analytical Landscape of Ropinirole: An In-Depth Review of an Indole-Based Dopaminergic Therapeutic Agent.

Exploring the Pharmaceutical Significance and Analytical Landscape of Ropinirole: An In-Depth Review of an Indole-Based Dopaminergic Therapeutic Agent.

Journal: Critical reviews in analytical chemistry

Published: November 21, 2025

Drug-induced urinary incontinence in pediatric patients: A disproportionality analysis of the FDA Adverse Event Reporting System.

Drug-induced urinary incontinence in pediatric patients: A disproportionality analysis of the FDA Adverse Event Reporting System.

Journal: Medicine

Published: October 28, 2025

Development of a 3D Printing Liquid Crystal Display (LCD)-Assisted Micromolding Methodology for Custom Fabrication of Polymeric Microneedles Using Experimental Design.

Development of a 3D Printing Liquid Crystal Display (LCD)-Assisted Micromolding Methodology for Custom Fabrication of Polymeric Microneedles Using Experimental Design.

Journal: Pharmaceutics

Published: October 24, 2025

Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease.

Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: September 12, 2025

Diagnosis and Treatment of Augmentation Syndrome Secondary to Ropinirole: A Case Report.

Diagnosis and Treatment of Augmentation Syndrome Secondary to Ropinirole: A Case Report.

Journal: Cureus

Published: August 29, 2025

Drug discovery research with the iPSC models of neurodegenerative diseases.

Drug discovery research with the iPSC models of neurodegenerative diseases.

Journal: Neuroscience research

Published: August 28, 2025

Onapgo - an apomorphine subcutaneous infusion for Parkinson's disease.

Onapgo - an apomorphine subcutaneous infusion for Parkinson's disease.

Journal: The Medical letter on drugs and therapeutics

Published: July 12, 2025

Rapid health technology assessment of six non-ergot dopamine-receptor agonists for the treatment of early Parkinson's disease.

Rapid health technology assessment of six non-ergot dopamine-receptor agonists for the treatment of early Parkinson's disease.

Journal: Frontiers in pharmacology

Published: June 18, 2025

Muscle bursting and corticomotor excitability mark impaired impulse control in Parkinson's disease.

Muscle bursting and corticomotor excitability mark impaired impulse control in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: May 19, 2025

Advanced P407/Tw80/βCD based Nasal Powders of Ropinirole Hydrochloride for Nose-to-Brain Delivery in Parkinson's Disease: Preparation and Comprehensive In Vitro and Ex Vivo Evaluation.

Advanced P407/Tw80/βCD based Nasal Powders of Ropinirole Hydrochloride for Nose-to-Brain Delivery in Parkinson's Disease: Preparation and Comprehensive In Vitro and Ex Vivo Evaluation.

Journal: The AAPS journal

Published: May 12, 2025

Cross-matrix multi-omics profiling identifies host-microbe interactions and diagnostic signatures in bovine subclinical mastitis.

Cross-matrix multi-omics profiling identifies host-microbe interactions and diagnostic signatures in bovine subclinical mastitis.

Journal: Frontiers in microbiology

Published: May 02, 2025

Showing 1-12 of 939

Last Updated: 02/24/2026